Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments
US10975139B1 · kind B1 · utility
4Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 18, 2020 |
| Grant date | Apr 13, 2021 |
| Priority date | — |
| Expiry date | Aug 18, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.